Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Stress and hormones like progesterone can affect absence seizures, but their effects change with different life stages.

A 71-year-old woman developed male-like features due to high testosterone levels caused by a benign ovarian tumor, which was successfully removed by surgery.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

SHBG binding properties are unchanged in male liver cirrhosis patients.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The document describes a treatment for excessive hair growth in a teenage girl using medication and birth control, but does not report the results.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Hormonal treatments like birth control pills can improve acne in women with excess hair growth and hormone imbalances.

Taking vitamin B6 corrected a pregnant woman's metabolic disorder, which changed her hair color.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

The dog's skin condition improved after removing a tumor that was causing hormone imbalances.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.